Cardiac, Thoracic and Vascular Surgery in the medical technology industry

Provider for Cardiac, Thoracic and Vascular Surgery in the medical technology industry


10 provider for Cardiac, Thoracic and Vascular Surgery found

Cardiac, Thoracic and Vascular Surgery in the medical technology industry

Cardiac, Thoracic and Vascular Surgery

Cardiac surgery has been an independent professional field since 1993, which has its origins in thoracic surgery and cardiovascular surgery in the 20th century. It includes surgical treatment of congenital and acquired diseases, as well as the heart and blood vessels near the heart. Hence, it is a topic that is closely related to cardiology and vascular surgery. The transplant plays an important role. However, the most common surgeries are coronary artery bypass grafts and heart valve surgery. Closely related topics are thoracic and vascular surgery, cardiology and pediatric cardiology. In the context of intensive care medicine for cardiac surgery, anesthesiology also overlaps.

Since the first successful replacement of the aortic valve with a mechanical prosthesis in 1960, new materials and new technologies have developed rapidly. However, all conventional valves have problems. Here thromboembolism or bleeding complications, valve endocarditis and unphysiological circulatory disorders are critical. The use of cryopreserved heart valve transplants (allografts) in humans has established safety procedures of its own for the treatment of heart valve disease in cardiac surgery. Although the ideal heart valve replacement surgery has not yet been determined, human allografts are the closest to this when compared to mechanical or biological valves. An allogeneic transplant can ensure an almost normal anatomical structure with good hemodynamic properties under static charge and pressure.

As the incidence of thromboembolic events is very low, anticoagulation therapy is usually not required. Due to the low reinfection rate of allografts, especially in endocarditis, it has proven to be particularly resistant to infection. However, due to the lack of organ donors, allogeneic transplants can only be used to a limited extent in all transplant medicines. They have an immunological potential, are subject to new degeneration processes due to calcification and therefore have limited long-term functions. Overall, it can be said that allografts are a more attractive alternative to mechanical or xenobiological prostheses for some patients. The attending physician should be informed about the implants, surgical methods and expected results.

Become a member of the “World Center for Medical Technology“

Become part of the largest medical technology cluster in Germany and benefit from a strong community.

Become a member